key: cord-0999674-ch9e60ql authors: Meyers, Peter H title: The Trump Administration’s Flawed Decision on coronavirus Vaccine Injury Compensation: Recommendations for Changes date: 2020-11-26 journal: J Law Biosci DOI: 10.1093/jlb/lsaa082 sha: 132bb68348939028692c1db1ecbb250b62d53911 doc_id: 999674 cord_uid: ch9e60ql The Trump Administration has announced that all claims for injuries that may be caused by the coronavirus vaccines now being developed must be filed in the Countermeasures Injury Compensation Program. This essay assesses the flaws in this program and advocates that it be substantially modified or that compensation claims be addressed via other significantly superior compensation programs. There is an urgent need for attention to this issue in light of intensive efforts being made to rapidly develop and distribute COVID-19 vaccines. It is important that a fair vaccine injury compensation program be available to the tens of thousands of volunteers who are currently participating in clinical trials to find a much-needed safe and effective vaccine. Once such a vaccine is approved, it is hoped that a substantial majority of Americans will take it. Failure to have a fair compensation program in place for all who receive the vaccines will give ammunition to Anti-Vaxxers and undermine the widespread use of these vaccines. In addition, only limited compensation is authorized by statute for those petitioners who successfully navigate the program. Already there is concern that while many Americans will welcome a coronavirus vaccine, only 51% of U.S. adults will definitely or probably take the vaccine if it were available, according to a Pew Research Organization poll in September 2020, down sharply from 72% who said they would take the vaccine in May 2020. 3 Such a low level of vaccination would jeopardize the herd immunity necessary to protect Americans throughout the country. The CICP is "the perfect target for anti-vaccinationists and others who believe that unsafe pandemic vaccines [are being] foisted upon a vulnerable public." 4 Congress needs to act to ensure that a better vaccine compensation program is in place that will provide confidence that when adverse reactions to the coronavirus vaccines occurwhich one hopes will be very rarethat adequate compensation will be provided to the injured persons. It is important to have a safety net in place now for the tens of thousands of volunteers participating in vaccine trials and then when coronavirus vaccines become widely available, so that there is assurance that claims for vaccine injuries will be promptly paid for medical expenses, lost income, and pain and suffering. Part II of this Article discusses the importance of preparing for the likelihood that 4/1/2020), at https://www.cdc.gov/vaccines/hcp/vis/vis-statements/dtap.html ("As with any medicine, there is a very remote chance of a vaccine causing a severe allergic reaction, other serious injury, or death."). 14 The CICP, 19 where the Trump Administration has decided that all coronavirus vaccine injury claims must be filed, was passed in 2005 at the direction of the George W. Bush Administration out of concern with a potential H1N1 avian flu pandemic as well as potential bioterrorism threats from anthrax and other toxins. 20 In order to encourage industry to participate in creating countermeasures to such threats, including developing new vaccines, the new law provided the industry with very sweeping liability protections. The CICP protects all manufactures, distributers, and dispensers of covered vaccines and other countermeasures from any liability for serious adverse consequences that result from the administration of the vaccines or other countermeasures, even when the company is guilty of gross negligence in producing its product or makes deceptive claims in marketing it. 21 The only exception is for "willful misconduct" by the company. 22 The CICP is an extremely restricted compensation scheme. All petitions for compensation are decided by HHS officials in secret, without the opportunity for petitioners to interact with the decision-makers. 23 There is no time limit for HHS to issue its decision, and no judicial review is allowed of adverse decisions. 24 All decisions to grant or deny compensation are also kept secret and never published, so that the public never knows which adverse events HHS has found related to the vaccine and 19 The CICP was attached to a "must pass" military authorization bill without any which were not. 25 Even for successful petitions, the compensation allowed is quite limited. Payments for medical expenses are allowed, but no compensation is allowed for pain and suffering, or for rehabilitation, special education or vocational therapies, and only partial, prorated compensation is allowed for lost income. 26 The program also has many other caps and exclusions for allowable compensation. 27 The CICP does not authorize the program to pay for attorneys' fees and the fees of doctors who submit expert reports in support of the petition, 28 While the VICP is far better than the CICP, it has its problems. There is a large backlog of cases today, and years-long delays in scheduling hearings in many pending cases. 43 attacks. 51 Congress also made clear, however, that the most important objective of the Act was "to protect the airline industry, the World Trade Center's owners, and others from protracted, uncertain litigation." 52 The 9/11 compensation fund used informal procedures to adjudicate all injury and death claims filed in the program, with Kenneth Feinberg acting as Administrator. 53 Feinberg and his deputies gave all individuals who filed claims in the program an opportunity to meet in person and to advocate for what they believed were appropriate levels of compensation. 54 The September 11th Compensation Fund required final decisions to be issued within 120 days of the claims being filed, and this provision was largely followed. 55 The Fund even allowed advance benefits to be paid before final resolution of the claims to injured claimants and survivors who could show severe hardship. The Fund ultimately granted compensation for 75% of the claims filed (compensation awarded for 5,560 claims out of 7,403 filed). 56 This author agrees with the many commentators who have concluded that the September 11th Fund largely succeeded in providing compensation that was generous, prompt, and fair to the petitioners. 57 Other commentators have criticized the September 11th Fund for the enormous discretion given to the Administrator with little accountability or oversight, 58 but this Author believes that the broad discretion given to the Administrator, which was exercised with compassion and flexibility, was responsible for the success of the program. The September 11th Compensation Fund was created in a different atmosphere than exists today, a time when Americans came together to respond to a national tragedy. The lawmakers who passed the September 11th Fund only eleven days after the attacks wanted to show the world that, in the face of such an unprecedented attack, the American people would rally around the victims. Like the Marshall Plan that rescued Europe after World War II, the 9/11 Fund was a demonstration of American resolve in the wake of tragedy. The Nation would stand as one. 59 This spirit of national unity after the 9/11 attacks stands in sharp contrast to the deep divisions in American society today in addressing the COVID-19 crisis. Notwithstanding the different atmosphere, the provisions of the September 11th Compensation Fund offer a useful model for structuring a fair and just compensation program for coronavirus vaccine injuries. Based on experience with prior compensation programs, the following recommendations are provided for the key provisions that should be part Compensation Fund required that final decisions on claims be issued within 120 days of filing, and this requirement was largely followed. 60 The VICP requires that final decisions be issued within 240 days of filing the claim, but this time limit has been largely ignored. 61 Because vaccine injury claims are generally more complex than the claims filed in the 9/11 Fund, a 240day limit for final decisions is appropriate, but it should be strictly enforced. and what injuries were found not compensable, and at least a brief description of the bases for these decisions. The names of the petitioners should be redacted at the request of petitioners to protect their privacy, as is done in the VICP. Adequate vaccine injury compensation should be a bipartisan priority for the new Administration and Congress. Instead of the CICP, a new program should be designed based on the best features of the VICP and the September 11th Victim Compensation Fund. By providing more generous funding and elemental procedural safeguards, there will be fairer compensation for the rare serious injuries and an effective rebuttal to the anti-vaccination movement. The September 11th Victim Compensation Fund: An Effective Administrative Response to National Tragedy Once was Enough, Wash. Post Final Report of the Special Master for the September 11th Victim Compensation Fund of 2001 Why the September 11th Victim Compensation Fund Proves the Case for a New Zealand-Style Comprehensive Social Insurance Plan in the United States, 100 Nw What Is Life Worth?: The Unprecedented Effort to Compensate the Victims of 9/11 (2005)) ("In fact, the resultant mix of presumptive scheduling tempered by personal empathy and pecuniary adjustments at the margin was the touchstone to the success of the program Tort and Welfare Principles in the Victim Compensation Fund benefit of the doubt" provision that mandated compensation if there was "an approximate balance of positive and negative evidence" with respect to a claimant's eligibility. 50 U.S.C. § 1989b-4(a Recalibrating Vaccination Laws provides: The reviewing court shall--(1) compel agency action unlawfully withheld or unreasonably delayed; and (2) hold unlawful and set aside agency action, findings, and conclusions found to be-(A) arbitrary, capricious, an abuse of discretion, or otherwise not in accordance with law; (B) contrary to constitutional right, power, privilege, or immunity; (C) in excess of statutory jurisdiction, authority, or limitations, or short of statutory right No-Fault Vaccine Insurance: Lessons from the National Vaccine Injury Compensation Program, 24